Digital Health that Scales

Why a platform approach to digital health could be the enlightened path to performance in life sciences.

WhitepaperPublished October 2022

Actually, it’s not so hard to create a digital health project. It’s not so hard to build software. It’s not so hard to get it online. But getting it to scale, creating an ecosystem, getting it adopted – those are the vital steps that confound us all.

This whitepaper addresses the problem every pharmaceutical company faces: adopting different DNA. The need to become expert in a different type of development, quite alien from the work of progressing chemical or biological therapies. It requires a new type of organisation, a new way of working and the ability to accept help.

We propose that help takes the form of a platform. A software platform designed to ensure you thrive in this ecosystem and have the highest chance of success. This paper explores the possibilities that a platform approach offers and the types available, evaluating their different features, qualities, pros and cons.

Contributors
Paul Simms - Headshot Photo

Paul Simms Chief Executive Impatient Health Read more

Caoimhe Vallely-Gilroy - Headshot Photo

Caoimhe Vallely-Gilroy Former Global Head Of Digital Health & Therapeutics Merck KGaA


John Mulcahy - Headshot Photo

John Mulcahy Vice President Of Product Management S3 Connected Health

Francesca Wuttke - Headshot Photo

Francesca Wuttke CEO And Founder Nen Health



Leslie Anne Fendt - Headshot Photo

Leslie Anne Fendt Global Integrated Solutions Product Leader – Digital Health Roche


Jim O’Donoghue - Headshot Photo

Jim O’Donoghue President S3 Connected Health


Wolfgang Schleifer - Headshot Photo

Wolfgang Schleifer Head of Digital Delivery Novartis

Shwen Gwee - Headshot Photo

Shwen Gwee Former Vice President and Head Of Global Digital Strategy BMS



Irina Osovskaya - Headshot Photo

Irina Osovskaya Global Digital Strategy Director AstraZeneca

Adam Higgins - Headshot Photo

Adam Higgins Head Of Digital Strategy, EMEA Janssen



Get your copy now

The path to performance

It’s clear that digital health solutions are going to become ever more central to pharma’s innovation proposition. Recent market wobbles will not change a genuine value proposition where companion or standalone digital health innovation bring tangible health benefits, patient satisfaction and improved data flow. We just need to bring this to market with greater surety. Find out how!

Overview

20 pages of insight

This paper was born from interviews with several of our industry’s most seasoned digital health players. It became clear that a better approach was needed for the development and distribution of digital health within large companies, at scale. And with increasing pressure on digital pipelines, we can no longer afford to play around: we need to capitalise on what we’ve learned about bringing projects into the real world, with a platform approach.

Download

Download your copy of the whitepaper